TCN2 and neoplasm: While previous analyses of bulk transcriptomic data through CIBERSORTx deconvolution had suggested the likely cellular source for TCN2 gene expression in sarcomatous tumors, our group sought to determine which cells differentially expressed TCN2 (for a variety of tumor types) using a method that provides single cell resolution to the complex and heterogenous tumor microenvironment (TME).